12.49
+0(+0.00%)
Currency In USD
| Previous Close | 12.49 |
| Open | 12.49 |
| Day High | 12.49 |
| Day Low | 12.49 |
| 52-Week High | 12.51 |
| 52-Week Low | 5.9 |
| Volume | 0 |
| Average Volume | 1.58M |
| Market Cap | 798.9M |
| PE | -5.18 |
| EPS | -2.41 |
| Moving Average 50 Days | 12.36 |
| Moving Average 200 Days | 10.25 |
| Change | 0 |
If you invested $1000 in Avid Bioservices, Inc. (CDMO) 10 years ago, it would be worth $1,631.35 as of March 12, 2025 at a share price of $12.49. Whereas If you bought $1000 worth of Avid Bioservices, Inc. (CDMO) shares 5 years ago, it would be worth $3,170.05 as of March 12, 2025 at a share price of $12.49.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience
GlobeNewswire Inc.
Feb 10, 2025 1:05 PM GMT
TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and man
Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger
GlobeNewswire Inc.
Feb 05, 2025 3:45 PM GMT
TUSTIN, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality develo
Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners
GlobeNewswire Inc.
Feb 05, 2025 2:55 PM GMT
Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completedGHO and Ampersand’s deep experience in CDMO investing to support Avid’s next stage of rapid growth including expanded offerings, talent investm
Data not available